Dr. Milton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
788 8th Ave SE
Ste 400
Cedar Rapids, IA 52401Phone+1 319-832-2328Fax+1 319-832-1168
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Clinical Cardiac Electrophysiology, 2002 - 2004
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2000 - 2004
- Johns Hopkins UniversityResidency, Internal Medicine, 1997 - 2000
- Johns Hopkins UniversityInternship, Internal Medicine, 1997 - 1998
- University of Texas Medical Branch School of MedicineClass of 1997
Certifications & Licensure
- IA State Medical License 2021 - 2026
- OK State Medical License 2004 - 2025
- MN State Medical License 2000 - 2005
- WI State Medical License 2002 - 2005
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Publications & Presentations
PubMed
- 2 citationsTEE-Guided Percutaneous Aspiration of a Large Lead-Associated Vegetation Prior to Transvenous Lead Extraction.Amad J Chohan, Beau M. Hawkins, Talla A. Rousan, Mark A Milton, Luis D Velazco-Davila
CASE. 2021-02-01 - Utility of intracardiac ultrasound imaging to guide pulmonary vein ablation using laser balloon catheter.Luiz Leite, Wilber Su, Susan B Johnson, Mark Milton, Benhur Henz
Arquivos Brasileiros De Cardiologia. 2009-12-01 - 164 citationsEfficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system.Alvaro Valentim Lima Sarabanda, T. Jared Bunch, Susan B. Johnson, Srijoy Mahapatra, Mark A. Milton
Journal of the American College of Cardiology. 2005-11-15
Press Mentions
- Adeno-Associated Virus Serotype 9 Antibodies in Patients Screened for Treatment with Onasemnogene AbeparvovecFebruary 24th, 2021
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: